Regulatory Compliance, Business Operations 31 Jan 2025 regulatory compliance, drug importation, dea, controlled substances, catalent greenville

⚖️DEA Notice

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Compliance, Regulatory Requirements 8 Jan 2025 compliance, regulation, fda, debarment, fdca, drug importation, businesses

🚫FDA Denies Hearing; Jiao Debarred for Five Years from Drug Imports

The Food and Drug Administration (FDA or Agency) is denying a request for a hearing submitted by Yong Sheng Jiao, also known as Yongsheng Jiao and Wilson Jiao (Jiao), and is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jiao for 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Jiao was convicted of a felony under Federal law for conduct relating to the importation into the United States of any drug or controlled substance under the FD&C Act. In determining the appropriateness and period of Jiao's debarment, FDA considered the relevant factors listed in the FD&C Act. Jiao submitted a request for hearing but failed to file with the Agency information and analyses sufficient to create a basis for a hearing.

Learn More